Calibrated automated thrombin generation measurement in clotting plasma
about
sameAs
Protein C Thr315Ala variant results in gain of function but manifests as type II deficiency in diagnostic assaysTowards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assayComparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber modelSmall Peptides Blocking Inhibition of Factor Xa and Tissue Factor-Factor VIIa by Tissue Factor Pathway Inhibitor (TFPI)Discovery and characterization of an antibody directed against exosite I of thrombinInitiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristicsAntithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actionsStatins but not aspirin reduce thrombotic risk assessed by thrombin generation in diabetic patients without cardiovascular events: the RATIONAL trialIdentification and multidimensional optimization of an asymmetric bispecific IgG antibody mimicking the function of factor VIII cofactor activityDifferential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosisChanging Concepts of Cirrhotic Coagulopathy.Cofactor activity in factor VIIIa of the blood clotting pathway is stabilized by an interdomain bond between His281 and Ser524 formed in factor VIII.Active site-labeled prothrombin inhibits prothrombinase in vitro and thrombosis in vivo.Platelet-targeting sensor reveals thrombin gradients within blood clots forming in microfluidic assays and in mouse.Coagulation changes during presyncope and recovery.Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis.Thromboelastography to monitor clotting/bleeding complications in patients treated with the molecular adsorbent recirculating systemCombination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts.Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion.Hyperferritinaemia in dengue virus infected patients is associated with immune activation and coagulation disturbancesProcoagulant profile in patients with immune thrombocytopenia.Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review.Prediction of bleeding risk in patients taking vitamin K antagonists using thrombin generation testing.Moderate plasma dilution using artificial plasma expanders shifts the haemostatic balance to hypercoagulation.Sucrose octasulfate selectively accelerates thrombin inactivation by heparin cofactor IISystems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood.The Phosphatase Inhibitor Calyculin-A Impairs Clot Retraction, Platelet Activation, and Thrombin Generation.Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency.Inhibition of thrombin formation by active site mutated (S360A) activated protein C.Factor VIII lacking the C2 domain retains cofactor activity in vitroSyncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity.Lack of recombinant factor VIII B-domain induces phospholipid vesicle aggregation: implications for the immunogenicity of factor VIIISelf-titrating anticoagulant nanocomplexes that restore homeostatic regulation of the coagulation cascade.Polyphosphate modulates blood coagulation and fibrinolysis.Levels of procoagulant microvesicles are elevated after traumatic injury and platelet microvesicles are negatively correlated with mortality.Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.Changes in thrombin generation and D-dimer concentrations in women injecting enoxaparin during pregnancy and the puerperium.Zymogen-like factor Xa variants restore thrombin generation and effectively bypass the intrinsic pathway in vitroAntiplatelet agents can promote two-peaked thrombin generation in platelet rich plasma: mechanism and possible applications.Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study
P2860
Q24317483-9E3855EF-70FB-4891-A3CD-EE3AB946880FQ24812269-16BCE868-EBA9-43D3-AACC-A8A5774CC407Q27330363-8F3245D5-025C-4F1F-B4A5-6448528D490FQ27680684-F045964C-A68C-4DB6-A932-784A725CD1B3Q27702300-69BF7FF3-99C9-46B6-8E70-0CF150B719F4Q28167653-B6EF0B17-34FA-4440-9E76-7821F3A9245DQ28211940-02138208-0334-4C46-811A-187C443073B6Q28481709-761905D3-07C8-4681-B630-61B40978DACDQ28487387-DDB2E569-F278-4248-BD0C-FB0FA52A4C8CQ28539503-E6E73407-A1E6-4A5D-A57B-03F253040723Q30275544-7CBCD8A7-6035-4796-BF49-7F62E807977BQ30360900-826B87B6-B930-45C5-98B2-9175B9E1DA5EQ30501624-AA438E5B-3969-4E81-BB6B-0B0CDEDEFC6EQ30582830-69427268-5B9F-4BEA-BB9C-8772F8E6EF8FQ33161632-45E5811C-1774-4EE8-A28D-C895411B6C77Q33318443-8E8250EB-A287-400B-8EC1-83EFC1D43EB5Q33395093-6A4E845E-9D1C-4F98-9B73-E1DD3F1C7DFAQ33404353-F74FCA34-C8ED-482C-926C-929F11EFFA25Q33404773-1EBE655C-AD06-41D5-980D-570FA4BCEB12Q33418083-44BF3A79-D2A9-4F1A-A8F3-FA2DAEF2E455Q33436189-7E29A470-3BBE-4DFF-B955-060DF616C5F8Q33440890-2E1249A8-7AF0-41D2-874E-AF3CE45F7339Q33637902-D1E1F5CB-2F86-4984-9660-9BE42DB8AE5DQ33678363-59A4EFF8-998A-438C-BFD1-0E60FBB7E0C7Q33707130-5881C345-8A8E-4CC3-9C5B-894B48D276C7Q33717037-00657AB5-9189-4492-BF5E-B99190CBD67EQ33819944-EC67D6BD-B6A2-4C75-86A6-2671798735F3Q33934481-F8107A07-F225-4AE9-B3CE-EB031DD082A4Q34003846-CCCB8963-010F-49C1-A111-CFAD5A7EA37CQ34055694-FCD0A89A-74B7-467B-BCE0-E69937C4F047Q34056273-6BEE93CD-AC49-40E5-9EF8-0356A4034056Q34111482-738E94C2-89B1-4B77-B433-D56D022C5916Q34239129-3653FA3D-2EF6-4C06-B3B6-20954DEDED4FQ34304738-46AA8369-F7DE-4A85-A7FE-E756196B0181Q34438775-4474BB89-20A4-44C5-BEE1-4C9B82BA04F2Q34479961-BD2B6F5E-28C4-4CB8-BF6C-DAE925E2CED5Q34558722-1556115A-4CF0-4B61-B460-D8A59C1D150AQ34568888-AA5A8F39-A199-482D-A212-C7CCDACECA7BQ34584420-1260984A-FE98-40AB-BA1F-CE8225E0B4F3Q34611568-3BA4EA71-933B-40C9-B5DD-44ED41D28D4A
P2860
Calibrated automated thrombin generation measurement in clotting plasma
description
2003 nî lūn-bûn
@nan
2003 թուականին հրատարակուած գիտական յօդուած
@hyw
2003 թվականին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Calibrated automated thrombin generation measurement in clotting plasma
@ast
Calibrated automated thrombin generation measurement in clotting plasma
@en
Calibrated automated thrombin generation measurement in clotting plasma
@nl
type
label
Calibrated automated thrombin generation measurement in clotting plasma
@ast
Calibrated automated thrombin generation measurement in clotting plasma
@en
Calibrated automated thrombin generation measurement in clotting plasma
@nl
prefLabel
Calibrated automated thrombin generation measurement in clotting plasma
@ast
Calibrated automated thrombin generation measurement in clotting plasma
@en
Calibrated automated thrombin generation measurement in clotting plasma
@nl
P2093
P3181
P356
P1476
Calibrated automated thrombin generation measurement in clotting plasma
@en
P2093
Eric de Smedt
Peter Giesen
Raed Al Dieri
Rob Wagenvoord
Suzette Béguin
Thomas Lecompte
Véronique Regnault
P3181
P356
10.1159/000071636
P407
P50
P577
2003-01-01T00:00:00Z